Viridian Therapeutics Statistics
Total Valuation
VRDN has a market cap or net worth of $1.50 billion. The enterprise value is $999.06 million.
Important Dates
The last earnings date was Wednesday, August 6, 2025, before market open.
| Earnings Date | Aug 6, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
VRDN has 81.66 million shares outstanding. The number of shares has increased by 41.68% in one year.
| Current Share Class | 81.66M |
| Shares Outstanding | 81.66M |
| Shares Change (YoY) | +41.68% |
| Shares Change (QoQ) | +0.31% |
| Owned by Insiders (%) | 0.04% |
| Owned by Institutions (%) | 96.95% |
| Float | 67.25M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 5,047.00 |
| Forward PS | 58.22 |
| PB Ratio | 4.72 |
| P/TBV Ratio | 4.72 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 3,275.61 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 11.01, with a Debt / Equity ratio of 0.04.
| Current Ratio | 11.01 |
| Quick Ratio | 10.71 |
| Debt / Equity | 0.04 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -125.45 |
Financial Efficiency
Return on equity (ROE) is -65.88% and return on invested capital (ROIC) is -42.61%.
| Return on Equity (ROE) | -65.88% |
| Return on Assets (ROA) | -39.77% |
| Return on Invested Capital (ROIC) | -42.61% |
| Return on Capital Employed (ROCE) | -70.14% |
| Revenue Per Employee | $2,133 |
| Profits Per Employee | -$1.93M |
| Employee Count | 143 |
| Asset Turnover | 0.00 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +24.97% in the last 52 weeks. The beta is 0.48, so VRDN's price volatility has been lower than the market average.
| Beta (5Y) | 0.48 |
| 52-Week Price Change | +24.97% |
| 50-Day Moving Average | 16.21 |
| 200-Day Moving Average | 16.85 |
| Relative Strength Index (RSI) | 60.80 |
| Average Volume (20 Days) | 732,237 |
Short Selling Information
The latest short interest is 11.68 million, so 14.30% of the outstanding shares have been sold short.
| Short Interest | 11.68M |
| Short Previous Month | 11.64M |
| Short % of Shares Out | 14.30% |
| Short % of Float | 17.36% |
| Short Ratio (days to cover) | 17.20 |
Income Statement
In the last 12 months, VRDN had revenue of $305,000 and -$275.74 million in losses. Loss per share was -$3.56.
| Revenue | 305,000 |
| Gross Profit | -304.27M |
| Operating Income | -371.59M |
| Pretax Income | -228.06M |
| Net Income | -275.74M |
| EBITDA | -371.10M |
| EBIT | -371.59M |
| Loss Per Share | -$3.56 |
Full Income StatementBalance Sheet
The company has $563.36 million in cash and $23.08 million in debt, giving a net cash position of $540.28 million or $6.62 per share.
| Cash & Cash Equivalents | 563.36M |
| Total Debt | 23.08M |
| Net Cash | 540.28M |
| Net Cash Per Share | $6.62 |
| Equity (Book Value) | 515.17M |
| Book Value Per Share | 4.00 |
| Working Capital | 526.17M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$309.06 million and capital expenditures -$535,000, giving a free cash flow of -$309.60 million.
| Operating Cash Flow | -309.06M |
| Capital Expenditures | -535,000 |
| Free Cash Flow | -309.60M |
| FCF Per Share | -$3.79 |
Full Cash Flow StatementMargins
| Gross Margin | n/a |
| Operating Margin | -121,831.15% |
| Pretax Margin | -112,806.89% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
VRDN does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -41.68% |
| Shareholder Yield | -41.68% |
| Earnings Yield | -17.91% |
| FCF Yield | -20.11% |
Analyst Forecast
The average price target for VRDN is $38.80, which is 110.87% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $38.80 |
| Price Target Difference | 110.87% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (5Y) | 407.03% |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on November 13, 2020. It was a reverse split with a ratio of 1:15.
| Last Split Date | Nov 13, 2020 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
VRDN has an Altman Z-Score of 7.89 and a Piotroski F-Score of 1.
| Altman Z-Score | 7.89 |
| Piotroski F-Score | 1 |